COMBINATION ANTICHOLINERGIC/LONG-ACTING BRONCHODILATOR
Anoro Ellipta is a prescription drug approved by the Food and Drug Administration (FDA) as long-term, once-daily maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary disease (COPD). Anoro Ellipta is a combination drug composed of Umeclidinium and Vilanterol.
Umeclidinium is a long-acting anticholinergic drug. Vilanterol is an ultra-long-acting beta2 adrenoreceptor agonist (ultra-LABA). Both drugs are believed to work by relaxing smooth muscles in the airways.
How do I take it?
Anoro Ellipta is taken once daily by oral inhalation.
Anoro Ellipta comes in the form of foil blister pack containing powder. Anoro Ellipta is... read more